Cargando…
Drug Repurposing for Japanese Encephalitis Virus Infection by Systems Biology Methods
Japanese encephalitis is a zoonotic disease caused by the Japanese encephalitis virus (JEV). It is mainly epidemic in Asia with an estimated 69,000 cases occurring per year. However, no approved agents are available for the treatment of JEV infection, and existing vaccines cannot control various typ...
Autores principales: | Lv, Bo-Min, Tong, Xin-Yu, Quan, Yuan, Liu, Meng-Yuan, Zhang, Qing-Ye, Song, Yun-Feng, Zhang, Hong-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320907/ https://www.ncbi.nlm.nih.gov/pubmed/30567313 http://dx.doi.org/10.3390/molecules23123346 |
Ejemplares similares
-
Identification and isolation of Genotype-I Japanese Encephalitis virus from encephalitis patients
por: Wang, Lihua, et al.
Publicado: (2010) -
Generation and characterization of Japanese encephalitis virus expressing GFP reporter gene for high throughput drug screening
por: Zhang, Zhe-Rui, et al.
Publicado: (2020) -
Japanese encephalitis: The virus and vaccines
por: Yun, Sang-Im, et al.
Publicado: (2014) -
Genotype V Japanese Encephalitis Virus Is Emerging
por: Li, Ming-Hua, et al.
Publicado: (2011) -
Mesenchymal stem cells alleviate Japanese encephalitis virus-induced neuroinflammation and mortality
por: Bian, Peiyu, et al.
Publicado: (2017)